GENinCode (LON:GENI – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.
GENinCode Stock Down 21.9%
Shares of GENinCode stock opened at GBX 0.68 on Tuesday. The stock has a market capitalization of £5.14 million, a price-to-earnings ratio of -0.33 and a beta of 0.59. GENinCode has a twelve month low of GBX 0.64 and a twelve month high of GBX 4.90. The company has a current ratio of 0.93, a quick ratio of 15.88 and a debt-to-equity ratio of 117.74. The business’s 50 day simple moving average is GBX 0.88 and its 200-day simple moving average is GBX 0.99.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Recommended Stories
- Five stocks we like better than GENinCode
- 2 Short-Squeeze Candidates Waiting for the Right Catalyst
- MongoDB Stock Drops 17% After CEO Exit—What Investors Should Know
- Bernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
